Damien Simoneau

868 total citations
17 papers, 644 citations indexed

About

Damien Simoneau is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Damien Simoneau has authored 17 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Pharmacology and 4 papers in Clinical Biochemistry. Recurrent topics in Damien Simoneau's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Damien Simoneau is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Damien Simoneau collaborates with scholars based in France, United States and Italy. Damien Simoneau's co-authors include Hartmut Schmidt, Leslie Amass, Isabel Conceição, Alejandra González‐Duarte, Laura Obici, Moh‐Lim Ong, Christian Eckmann, Philippe Montravers, Matteo Bassetti and W. R. Heizmann and has published in prestigious journals such as Gut, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

Damien Simoneau

14 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damien Simoneau France 12 212 165 120 103 90 17 644
M. Christofidou Greece 14 49 0.2× 258 1.6× 73 0.6× 32 0.3× 63 0.7× 25 573
John L. Clark United States 10 105 0.5× 81 0.5× 42 0.3× 80 0.8× 53 0.6× 23 595
Rishi Jain United States 15 106 0.5× 85 0.5× 98 0.8× 169 1.6× 15 0.2× 62 685
C.C. Chu Taiwan 9 137 0.6× 186 1.1× 287 2.4× 113 1.1× 44 0.5× 15 1.5k
A. Pinna United States 6 40 0.2× 171 1.0× 170 1.4× 258 2.5× 31 0.3× 10 569
Margherita Macera Italy 17 91 0.4× 627 3.8× 111 0.9× 59 0.6× 79 0.9× 60 987
Maria Raftogiannis Greece 16 105 0.5× 400 2.4× 56 0.5× 53 0.5× 26 0.3× 27 684
Kang Hoe Lee Singapore 10 89 0.4× 487 3.0× 72 0.6× 95 0.9× 25 0.3× 11 1.2k
Michiya Yokozaki Japan 14 113 0.5× 118 0.7× 35 0.3× 114 1.1× 9 0.1× 37 517
Yasutaka Nakamura Japan 12 87 0.4× 64 0.4× 85 0.7× 95 0.9× 32 0.4× 64 385

Countries citing papers authored by Damien Simoneau

Since Specialization
Citations

This map shows the geographic impact of Damien Simoneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Simoneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Simoneau more than expected).

Fields of papers citing papers by Damien Simoneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Simoneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Simoneau. The network helps show where Damien Simoneau may publish in the future.

Co-authorship network of co-authors of Damien Simoneau

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Simoneau. A scholar is included among the top collaborators of Damien Simoneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Simoneau. Damien Simoneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Rangarajan, Savita, M. Joseph John, Shashikant Apte, et al.. (2022). Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India. Indian Journal of Hematology and Blood Transfusion. 39(4). 624–629.
3.
Rangarajan, Savita, M. Joseph John, Shashikant Apte, et al.. (2022). Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India. Indian Journal of Hematology and Blood Transfusion. 39(4). 630–634.
4.
Quarta, Cristina, Marianna Fontana, Thibaud Damy, et al.. (2022). Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. Frontiers in Cardiovascular Medicine. 9. 1073503–1073503. 13 indexed citations
5.
Bolanowski, Marek, Mirjana Doknić, Václav Hána, et al.. (2022). Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan. Frontiers in Endocrinology. 13. 816426–816426. 7 indexed citations
6.
Conceição, Isabel, Alejandra González‐Duarte, Laura Obici, et al.. (2015). “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy. Journal of the Peripheral Nervous System. 21(1). 5–9. 199 indexed citations
7.
Nathwani, Dilip, Christian Eckmann, W. Lawson, et al.. (2014). Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clinical Microbiology and Infection. 20(10). 993–1000. 47 indexed citations
8.
Nathwani, Dilip, Christian Eckmann, W. Lawson, et al.. (2014). Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infectious Diseases. 14(1). 476–476. 16 indexed citations
9.
10.
Eckmann, Christian, Philippe Montravers, Matteo Bassetti, et al.. (2013). Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. Journal of Antimicrobial Chemotherapy. 68(suppl 2). ii25–ii35. 59 indexed citations
11.
Montravers, Philippe, Matteo Bassetti, Hervé Dupont, et al.. (2013). Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. Journal of Antimicrobial Chemotherapy. 68(suppl 2). ii15–ii24. 31 indexed citations
12.
Heizmann, W. R., Herbert L. DuPont, Philippe Montravers, et al.. (2013). Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies. Journal of Antimicrobial Chemotherapy. 68(suppl 2). ii45–ii55. 16 indexed citations
13.
Guirao, Xavier, Miguel Sánchez García, Matteo Bassetti, et al.. (2013). Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies. Journal of Antimicrobial Chemotherapy. 68(suppl 2). ii37–ii44. 22 indexed citations
14.
Bassetti, Matteo, Christian Eckmann, Herbert L. DuPont, et al.. (2013). Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies. Journal of Antimicrobial Chemotherapy. 68(suppl 2). ii5–ii14. 22 indexed citations
15.
16.
Dowell, James A., et al.. (2008). The pharmacokinetics of dalbavancin in subjects with mild, moderate, or severe hepatic impairment. Critical Care. 12(Suppl 2). P25–P25. 5 indexed citations
17.
Roque-Afonso, A.M., Cyrille Féray, Didier Samuel, et al.. (2002). Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut. 50(1). 95–99. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Christofidou Breakdown of academic impact, for papers by John L. Clark Breakdown of academic impact, for papers by Rishi Jain Breakdown of academic impact, for papers by C.C. Chu Breakdown of academic impact, for papers by A. Pinna Breakdown of academic impact, for papers by Margherita Macera Breakdown of academic impact, for papers by Maria Raftogiannis Breakdown of academic impact, for papers by Kang Hoe Lee Breakdown of academic impact, for papers by Michiya Yokozaki Breakdown of academic impact, for papers by Yasutaka Nakamura
Rankless by CCL
2026